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ABSTRACT 
Discovering disease-gene associations is an essential but 
challenging task in modern medicine. Within all the data-driven 
approaches targeting at this issue, literature-based knowledge 
discovery widely extends the discovering boundaries and 
uncovers implicit knowledge from unstructured textual data. 
However, most of the current literature-based methods require the 
involvement of specific expertise or prior knowledge. In this 
paper, we propose an adaptable and transferable methodology to 
1) identify crucially genetic factors for a specific disease and 2) 
predict emerging genetic associations for the disease. Specifically, 
biomedical entities including diseases, chemicals, genes and 
genetic variations are extracted from literature data, then a 
heterogenous co-occurrence network is constructed and a 
semantic adjacency matrix is generated using the idea of 
Word2Vec. Following this, key genes and genetic variats are 
identified through centrality measurement on the network; 
emerging disease-gene associations are captured via a link 
prediction approach enhanced by the semantic matrix. We applied 
the proposed methodology to a literature dataset containing 
54,219 scientific articles of atrial fibrillation (AF) to demonstrate 
its reliability. The results yielded a) crucial biomedical entities for 
AF highlighting five key gene groups and one potentially 
associated protein mutation; b) a list of emerging AF-genetic 
factors pairs that are worth in-depth exploration. 
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In modern medicine, deciphering disease-associated genes plays a 
vital role in the diagnosis, treatment and prevention of diseases. 
However, apart from the handful revealed molecular mechanisms 
and disease pathogenesis, there is still a substantial amount of 
disorders and abnormalities with their causes remaining 
underneath the tip of the iceberg, especially for the process and 
factors related to the inheritance and genetic basis. In the past few 
years, many efforts have been addressed on exploring the genetic 
basis of diseases. Although in the biomedical domain, genetic 
linkage analysis [1] and genome-wide association studies 
(GWAS) [2] are recognized as efficient and reliable methods in 
identifying disease-specific genes, the biggest challenge for those 
methods turns out to be the long list of gene candidates, resulting 
in the high economic costs, human efforts and trail risks for those 
experiments. 
In the past decades, researchers established various medical 
ontologies and curated molecular networks to analyze and infer 
molecular interactions for diseases based on accumulated 
experimental and clinical experience [3-8]; Though these curated 
knowledge bases provide structuralized data sources for genetic 
discovery, their usages still face limitations from 1) the 
monotonicity of node category and the restriction of inference 
within the knowledge base framework; 2) the time lag of 
including novel discoveries and 3) the enormous cost from 
establishment and maintenance. 
The explosively increasing biomedical literature and thriving text 
mining techniques provide a more open, real-time and economic 
pathway to solve those issues [9-11]. Most of the approaches 
using literature datasets still require certain pre-knowledge-based 
input for the target disease like its seed genes [12]. In this paper, 
we proposed an adaptable bibliometric methodology to infer 
disease-associated genetic factors by 1) excavating more 
categories (disease, chemical and four other genetic factors) of 
biomedical entity from the textual data; 2) utilizing the collected 
literature dataset to identify emerging genetic factors for the target 
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disease; 3) empowering our methodology purely data-driven and 
automatic without biomedical expertise or manual effort. 
Our proposed methodology includes 1) a heterogenous 
bibliometric network [13]: the network is constructed based on 
biomedical literature with its nodes representing biomedical 
entities (e.g., diseases, chemicals, and genetic factors) and edges 
referring to the sentence-level co-occurrence between the 
connected nodes; 2) a Bioentity2Vec model: Using the idea of 
Word2Vec [14], all the biomedical entities are represented by 
computable vectors, from which an adjacency matrix containing 
their pairwise semantic similarities is generated; 3) network 
analytics: centrality measurement [15] is exploited to identify 
crucial diseases, chemicals and genetic factors within the network; 
a semantic similarity-enhanced link prediction approach [16] is 
proposed to improve the performance of predicting emerging 
disease-gene associations. 
2 Methodology 
The research framework of the proposed method is given in 
Figure 1. 
 
Figure 1: The Research Framework of the Heterogeneous 
Network Analytics Based Prediction Method 
2.1  Entity Extraction and Network Construction 
Four categories of biomedical entity are extracted from our 
literature dataset including: 1) disease: disease entity include 
disorders, symptoms, risk factors and complications related to the 
target disease; 2) chemical: chemical entity contains chemical 
elements, clinical drugs and other chemical compounds; 3) gene: 
the unit of hereditary information that occupies a fixed position 
(locus) on a chromosome; 4) Genetic Variant: genetic variants 
include DNA mutation, protein mutation and single nucleotide 
polymorphism (SNP): DNA mutation refers to the permanent 
change of a DNA sequence, protein mutation is the protein 
encoded by a gene with mutation and SNP [17] represents the 
normal variation of a single nucleotide in the gene sequence. 
Genes and genetic variants are the genetic factors we aim to 
predict in this study. 
Working under the hypothesis that sentence-level occurrence 
indicates a strong association between entity pairs, we treated the 
extracted entities as nodes and assigned edges aligning with their 
sentence-level co-occurrence. In this way all the entities and their 
co-occurring relationships are transferred into a heterogeneous 
network, with its nodes representing entities and edges 
representing sentence-level co-occurrence as the following 












𝑚 represents the 𝑚th node in the 𝑖th category, 
𝐶𝐹(𝑉𝑖
𝑚, 𝑉𝑗




The graph representation of the heterogeneous network is: 
𝐺 = (𝑉𝐾 , 𝐸𝐾(𝐾+1)
2
) #(2)  
where 𝑉 is the set of 𝐾 categories of entity nodes and 𝐸 
is the set of 𝐾(𝐾 + 1)/2  types of edges connecting different 
categories of nodes.  
2.2  Bioentity2Vec Modelling 
Enlightened by the idea of the Word2Vec model [14], we 
obtained the semantic similarities of biomedical entities from a 
context-based perspective. Word2vec is a well-accepted natural 
language model which can transfer word into vectors by 
projecting word its one-hot representation into a lower dimension 
and largely reserve their semantic meanings. In our case, 
biomedical entities are regarded as words and their consecutive 
sequences form our training corpus. We select the Skip-Gram as 
our training algorithm since it offer better fit on small datasets, the 
training process of Skip-Gram can be concluded as: given an 
entity 𝐸(𝑖) in a corpus, the probabilities of its nearby entities in a 
certain window size w will be calculated based on the probability 
of the given entity 𝐸(𝑖)  [18], the global objective of is 
maximizing the following value which calculates the average 










Through the Bioentity2Vec training, each entity would be 
represented as a fixed dimensional vector; we could then calculate 
the pairwise similarity of entities via cosine similarity and 
generate an adjacency similarity matrix 𝑆𝑉𝑖
𝑚𝑉𝑗
𝑛: 
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𝑚 is the corresponding vector of entity node 𝑉𝑖
𝑚. 
2.3  Network Analytics 
2.3.1 Centrality Measurement 
Centralities are a set of measurements evaluating nodes’ position 
and importance within the network [15]. In our study, degree 
centrality, closeness centrality and betweenness centrality are 
employed to identify the crucial nodes in our heterogeneous 
network; the three centralities respectively reflects the node’s 
capacity of aggregating, disseminating and transferring 
information within the network, besides they have also been 
proved to be efficient in identifying key roles in biomedical entity 
networks [19]. The explanations of three centralities are as 
follows: 
Degree Centrality (DC): the degree centrality measures the 
target node’s direct influence to other nodes by calculating the 
proportion of degrees that the target node possesses. An entity 
with high degree centrality indicates that it directly interacts with 













where |𝑉𝐾| is the number of all K categories of nodes in 
the network and |𝑉𝑗| represents the node number in the 𝑗 th 
category; 
Closeness Centrality (CC): this closeness centrality calculates 
the target node’s topological distance to all the other nodes in the 
network, the higher closeness centrality indicates the entity’s 
stronger capacity to reach all the other nodes within the network, 


















Betweenness Centrality (BC): the betweenness centrality of a 
target node is the ratio of shortest paths between other node pairs 
that pass through the target node, it indicates the node’s potential 
to bridge other nodes in the network. In our network, a higher 
betweenness centrality reflects that the entity is highly likely to be 
an important connector or transmitter:  
𝐵𝐶(𝑉𝑖
𝑚) =






























𝑚 is the number of paths that 
pass through node 𝑉𝑖
𝑚 among all of them. 
To further comprehensively measure the entities’ importance 
using the three centralities, non-dominated sorting is used to 
combine the three centrality rankings for each entity category. 
Non-dominated sorting is a multiple-objective optimization 
method which re-rank the multi-dimensional scalable individuals 
by dominating relationships of one individual against another, 
after non-dominated sorting the individuals will be divided into 
several consecutive Pareto fronts according to their domination 
counts [20]. The pseudo-code of non-dominated sorting is 
presented in Figure 2. 
 
Figure 2: The pseudo-code for non-dominated sorting 
2.3.2 Semantic Similarity-Enhanced Link Prediction  
Link prediction is an approach used to fulfil the incomplete 
network or in predicting future emerging links in networks [21]. 
Based on our previous pilot studies, resource allocation (RA) is 
the best-performing algorithm among all neighbor-based 
comparisons [16], it assumes that every single node in a network 
has a unit of resources and the common neighbor of two nodes 
plays the role of the transmitter, evenly distributing the unit of 
resource to its connected nodes. The resource allocation index of 
any two unconnected nodes is the summarization of those 
resources allocated by all their common neighbors, which 
indicates the potential link strength between the two nodes. The 
higher this index value is, the greater is the possibility of a link 
emerging between them.  
A weighted version of this algorithm was also introduced for 
applications in weighted networks [22], assuming that the co-
occurring frequency and semantic similarity of connected node 
pairs could enhance the predicting accuracy, we incorporated the 
cosine similarities matrix generated from the Bioentity2Vec 
model before to modify this algorithm, the modified resource 






























𝑛)) == 𝐹𝑎𝑙𝑠𝑒: 
for 𝑉𝑖 in 𝑉𝐾: 
for node 𝑉𝑖
𝑚 in 𝑉𝑖: 
    𝐷𝑜𝑚𝑖𝑛𝑎𝑡𝑖𝑜𝑛[𝑉𝑖
𝑚] = 0 # Initialize the Domination Counts 
        for node 𝑉𝑖
𝑛 in category 𝑖 (𝑚 ≠ 𝑛): 
 if  
     𝐷𝑜𝑚𝑖𝑛𝑎𝑡𝑖𝑜𝑛[𝑉𝑖
𝑚] += 1 
Resort all the nodes in 𝑉𝑖 by descending 𝐷𝑜𝑚𝑖𝑛𝑎𝑡𝑖𝑜𝑛 counts 
Output: 𝐾 Sorting results for 𝐾 categories 
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𝑚) denotes the set of neighbor nodes of 𝑉𝑖
𝑚 
and 𝐶𝐹(𝑉𝑖
𝑚, 𝑉𝑡) is the co-occurring frequency of 𝑉𝑖
𝑚 and 𝑉𝑡 , 𝑆𝑉𝑖𝑚𝑉𝑡  
denotes the semantic similarity of 𝑉𝑖
𝑚 and 𝑉𝑡. 
Using the genetic factors that haven’t co-occurred with the target 
disease before as our input, we could generate another final output 
through our link prediction approach: a ranking list of genetic 
factors with their corresponding predicting scores. The highly 
ranked ones are worth being validated by further biomedical 
experiments. 
3 Case Study 
Atrial fibrillation (AF) is the most common form of cardiac 
arrhythmia. The progress of AF is closely related to atrial size and 
the extent of atrial fibrosis, both of which are affected by genetic 
factors. Though several gene groups and mutations have been 
linked to AF, clinical evidence and mechanistic explanations are 
still far from being enough to integrate the knowledge of genetic 
risk factors into clinical practice [23]. Ongoing research is 
investigating discovered genes and seeking new gene associations. 
For these reasons, the choice of atrial fibrillation as our research 
topic here is both an appropriate and worthwhile undertaking.  
3.1  Data Collection 
PubMed is a biomedical literature search engine which comprises 
more than 30 million citations from MEDLINE database, PMC 
citations and other online book resources. We used “atrial 
fibrillation” as the searching term in PubMed and refined the 
search results by restricting the fields “species” to “humans”, 
MeSH searching was adopted to promise precise AF-related 
search results and no restriction was applied to publication date. 
In all, 54,219 records were retrieved from the exact searching 
query: 
“("Atrial Fibrillation"[Mesh] AND Humans[Mesh])” 
 Search Date: 2020/04/28 
3.2  Entity Extraction and Network Construction 
We exploited the Pubtator [24], Medical Subject Headings 
(MeSH) 1 , NCBI Homo-Sapiens Gene Dictionary 2  and dbSNP 
database to extract biomedical entities from the collected literature 
dataset. Pubtator is a deep learning-based entity extraction tool 
developed by the National Library of Medicine (NLM), it can 
automatically extract categorized biomedical concepts from the 
free texts. MeSH is a medical thesaurus covering all the disease 
and chemical concepts, NCBI Homo-Sapiens Gene Dictionary is a 
gene dictionary of homo-sapiens species; dbSNP database 
embodies genetic variants within the human genome, the most of 
discovered DNA mutations, protein mutation and SNP can be 
                                                                
1 More information could be found at https://www.ncbi.nlm.nih.gov/mesh/ 
2 More information could be found at https://www.ncbi.nlm.nih.gov/gene/ 
matched to a specific SNP ID. Generally, concepts cannot be 
mapped to these dictionaries would be excluded. 
Using Pubtator API and we extracted 577,809 raw biomedical 
concepts from the 54,219 records. With the aid of MeSH and 
NCBI gene dictionary, we cleaned noise concepts and 
consolidated all the synonyms, generating 6,318 identical 
biomedical entities; furtherly we excluded those entities that never 
co-occurred with others before (i.e., the isolated nodes that are not 
connected to any other nodes in the network) and ended up with 
5,838 nodes. The stepwise results are given in Table 1.   





Disease 440,610 Remove those diseases and 
chemicals that cannot map 
to MeSH, like 
“cardioembolic”, “JAGS”, 
“nonvitamin”, etc; 
Consolidation Based on 
MeSH 
2,040 
Chemical 104,072 2,004 
Gene 31,209 
Exclude genes that do not 
belong to homo-sapiens 
species; Consolidate gene 






223 #1 Remove genetic variants 
without a clear varying 
locus (cannot match to a 
SNP ID) and match the 




Total 577,809  5,838 
Note: #1 DNA mutation; #2 Protein mutation; #3 SNP. 
Through the sentence-level co-occurrence analysis, we 
constructed the heterogeneous network with 5,838 nodes and 
48,988 edges.  
  





3.3  Identification of Core Entities for AF 
To identify the crucial biomedical entities in the AF progress, we 
respectively calculated the degree, closeness and betweenness 
centralities for all the nodes in our heterogeneous network, the 
gene entities in the top 20 of each centrality ranking list are given 
in Table 2. 
Table 2: Top 20 Genes with Respectively the Highest Degree, 








1 CRP CRP KCNA5 
2 IL6 NPPB CRP 
3 NPPB ACE SCN5A 
4 F2 F2 F2 
5 ACE IL6 ACE 
6 AGT INS AGT 
7 F10 COX8A TBX5 
8 KCNA5 BID PITX2 
9 SCN5A VWF IL6 
10 FGB F10 SOX5 
11 INS AGT KCNQ1 
12 COX8A REN TRPM7 
13 TGFB1 FGB TRPC3 
14 MMP9 NPPA GJA5 
15 TNF CD59 HCN4 
16 VWF MMP9 F10 
17 GJA5 TNF TNNI3 
18 PITX2 SELP TRPM6 
19 SELP TGFB1 TRPM4 
20 REN TNNI3 GATA6 
From the observation of their centrality characteristics, we 
classified the gene nodes into 5 groups and analyzed their 
topological features and node composition with the aid of NCBI 
gene database3 and biomedical literature investigation: 
1. High Degree & Closeness & Betweenness Centralities: 
These topological features reflect the dominating positions of 
                                                                
3 More information could be found at https://www.ncbi.nlm.nih.gov/gene/ 
these nodes in the AF heterogeneous network. CRP, IL6, 
AGT, ACE, F2 and F10 are genes belong to this group; they 
are all early-discovered genes and have broad functioning 
ranges and massive interactions with other entities. 
Specifically, C-reactive protein (CRP) and interleukin 6 (IL6) 
are genes that function in inflammation reaction and the 
immune-related activities, with their encoding product’s 
levels associated with the prediction of a wide variety of 
cardiovascular events including AF; Angiotensin I 
converting enzyme (ACE) and angiotensinogen (AGT) are 
two chain functioning genes with the former encoding pre-
angiotensinogen which would be cleaved by the angiotensin I 
converting enzyme encoded by the later, the product 
angiotensin II from this process is a significant protein in 
controlling the blood pressure (BP) and fluid-electrolyte 
balance, so both BP related symptoms like hypertension and 
electrolyte adjustment chemicals are associated with the two 
genes; coagulation factor II (F2) and coagulation factor X 
(F10) are genes that encode major coagulation factors to 
intermediate blood clotting and hemorrhagic conditions 
related to AF. Conclusively, activities of genes in this group 
may not directly result in AF but their functions engage the 
most primary and foundational molecular mechanisms in the 
progress of AF. 
2. High Degree & Betweenness Centralities but low Close 
Centrality: From a graph theory perspective, we can interpret 
this group of gene nodes as the critical but localized 
controllers. This group of genes includes KCNA5 and 
SCN5A, both of which are also seed genes for AF with their 
associations with AF already revealed: KCNA5 and SCN5A 
respectively encode proteins for potassium and sodium 
voltage-gated channels, the loss or alternation of those 
channels’ function have a direct influence on the action 
potential and electrical activity of cardiomyocytes which 
may further lead to AF. For this group, gene nodes bridle the 
ion channel-related entities including symptoms and 
chemicals but one node majorly only covers one certain type 
of ion channel.  
3. High Degree & Close Centralities but low Betweenness 
Centrality: This group of gene nodes are inclined to be 
central nodes in their sub-components with high 
independence. NPPB, FGB, COX8A, VWF and INS are genes 
in this group, in which NPPB encodes the cardiac hormone 
with its blood concentration indicating the heart failure; FGB 
encodes the beta component of fibrinogen with whose 
deficiency or mutation leading to afibrinogenemia; COX8A 
encodes the terminal enzyme of the respiratory chain related 
to ATP synthesis and cardiomyopathy; VWF encodes a 
glycoprotein involved in hemostasis; INS is the gene in 
charge of insulin synthesis which is the critical chemical in 
diabetes. We could conclude that genes in this group are 
most directly associated with the most common AF risk 
factors or complications rather than AF itself.  
4. High Betweenness Centrality only: This group of genes 
including TBX5, SOX5 and PITX2 are less correlated to AF 
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compare with the aforementioned ones but the high 
betweenness centrality indicates their potential to connect AF 
with other entities. For example, TBX5 encodes transcription 
factor that is associated with heart developmental process 
and its mutation may result in a heart-affecting 
developmental disorder named Holt-Oram syndrome. 
5. High Closeness Centrality only: Topologically this group of 
gene it’s not the core nodes but still globally associated with 
the other AF entities. BID is the only gene in this group and 
it regulates cell’s apoptosis which is not a particular 
biological process for AF but generally correlated with other 
entities.  
Moreover, with applying non dominated sorting to all the node 
categories, we re-ranked the nodes for each category and 
generated Table 3 to further identify the other crucial entities. 
Table 3: Key Entities Identified from Centrality 
Measurements 
 Top 20 Results by Non-dominating Sorting 
Disease 
Atrial Fibrillation; Stroke; Heart Failure; 
Hypertension; Hemorrhage; Diabetes Mellitus; 
Fibrosis; Myocardial Infarction; Cerebral Infarction; 
Ischemia; Thromboembolism; Death; Thrombosis; 
Inflammation; Coronary Artery Disease; 
Tachycardia; Ventricular Fibrillation; Tachycardia, 
Supraventricular; Neoplasms; Atrioventricular 
Block 
Chemical 
Warfarin; Calcium; Amiodarone; Potassium; 
Digoxin; Ethanol; Verapamil; Sodium; Oxygen; 
Quinidine; Aspirin; Vitamin K; Glucose; 
Cholesterol; apixaban; Sotalol; Nitrogen; 
Magnesium; Heparin; Propafenone 
Gene 
CRP; F2; ACE; IL6; AGT; F10; SCN5A; NPPB; 
KCNA5; PITX2; FGB; GJA5; TNNI3; INS; TNF; 
TGFB1; VWF; KCNQ1; SERPINE1; AGTR1  
SNP 
rs2200733; rs6795970; rs2106261; rs2108622; 
rs3789678; rs13376333; rs17042171; rs1805127; 
rs7539020; rs11568023; rs10033464; rs3807989; 
rs7193343; rs3918242; rs3825214; rs16899974; 
rs699; rs7164883; rs6584555; rs10824026 
Apart from the genes which were evaluated before, we examined 
the reliabilities of other core entities respectively by looking 
through ClinVar [25] and SNPedia [26]; literature investigation 
was still used to provide supplementary evidence. 
The disease list presents the most common risk factors 
(Hypertension and Diabetes Mellitus), symptoms (Inflammation 
and Thrombosis), complications (Stroke and Heart Failure) and 
other correlating diseases (Hemorrhage, Fibrosis and Cerebral 
Infarction etc.) of AF, which are frequently reported in clinical 
cases. The chemical list highlights the regular treating drugs 
(Warfarin, Amiodarone, Digoxin, Verapamil, Quinidine, Aspirin, 
Apixaban, Sotalol, Heparin and Propafenone), the known 
pathological molecular mechanisms (Calcium, Sodium, Potassium 
and Magnesium channels) and risk factors (Ethanol and Glucose) 
of AF; Nitrogen and Oxygen are two other leading elements, 
resulting from the role of blood oxygen concentration as an 
indicating index and NOx as a risk factor in the progress of AF. 
To sum up, we regard the whole centrality measurement and non-
dominated sorting as a carding process for the AF-related 
biomedical entities, through which we not only captured the 
comprehensively critical biomedical entities but also gained clues 
on some potential AF-associated entities. 
3.4  Link Prediction Validation 
Before implementing the modified link prediction to our 
heterogeneous network, we performed a validating experiment on 
the rolled-back data to verify our algorithm’s usefulness on 
disease-gene association prediction. Two other link prediction 
algorithms were selected as our baselines: 
1. The original resource allocation (RA): the original version of 
resource allocation index mentioned before;  
2. the co-occurring frequency (CF) weighted version of 
resource allocation: this version of RA adopted the same 
assumption with RA but uses weight ratio instead of degree 
proportion to calculate the resource diffusion, in our study 
edge weight is by the entity’s co-occurring frequency; 
The validation experiment was designed as follows: We rolled 
back our dataset by a five-year gap and constructed a 
corresponding network (i.e., rolled-back network), and the newly 
researched 𝑘  AF-linked genes or SNPs in the latest five years 
were collected as true labels. Then, two baselines, as well as our 
modified version, were applied to the rolled-back network to 
predict emerging links. The predictive results are a mixed ranking 
list of genes and SNPs with their corresponding predictive scores. 
If a gene or SNP in true labels was correctly predicted in the top 𝑛  
(𝑛 is a selectable threshold according to predictive requirements, 
initially it was set as 𝑘 ) predicting list, it would count a true 
positive (TP), otherwise, it would constitute a false negative (FN). 

















Top Recall 0.245 0.212 0.283 
Top 100 Recall 0.436 0.392 0.502 
Top 200 Recall 0.610 0.632 0.742 
From the results we can see that the modified link prediction 
approach method beat the other two baselines. This experiment 
fully proved the efficiency of our proposed method. Briefly, in the 
top 200 list, our algorithm successfully captured 74% of the 
correct genetic factors which would appear in the following five 
years, from an applying standpoint it largely reduces the necessary 
human workload by using the predictive shortlist to select 
candidate genetic factors.  
3.5 AF-related Genetic Factors Prediction 
We applied our proposed method to the heterogeneous network 
and obtained a list of disease-gene pairs listed in Table 5. Then we 
empirically searched evidence from literature to validate our 
predication and found that the top 10 could all be linked according 
to literature review. The predicted SNPs are attracting more 
attention in the latest research of AF [27] and the other genes are 
also more frequently studied in the given literature. For example, 
rs337711 (ranked 2 in our list), is a genetic variation in KCNN2 
engaging with the potassium voltage-gated channels and has 
influence on the action potential and electrical activity of 
cardiomyocytes related to AF [23]. The association of rs11264280 
(ranked 3 in our list) is reported to be contract from two separate 
experiments [27, 28]. One of PKP2 (ranked 5 in our list) 
mutations was reported to has a potential influence on atrial size 
and  another deletion mutation was reported to be related to the 
occurrence of lone AF [29, 30]. Warfarin, a commonly prescribed 
anticoagulant for nonvalvular AF, is facing a medication shift 
because of the adverse effect of valvular calcification due to gene 
MGP (ranked 9 in our list) [31]. The combination of TFF3 
(ranked 10 in our list) and P3NP has the potential to be a 













1 Gene | BGLAP 3.13 [33] 
2 SNP | rs337711 2.13 [34, 35] 
3 SNP | rs11264280 2.13 [27, 28] 
4 Gene | HP 2.11 [36] 
5 Gene | PKP2 2.05 [29, 30] 
6 Gene | DUOX2 1.91 [37] 
7 Gene | OLR1 1.88 [38] 
8 Gene | VIM 1.87 [39] 
9 Gene | MGP 1.84 [31] 
10 Gene | TFF3 1.83 [32, 40] 
4 Discussion 
Identifying disease-gene associations is a critical part of modern 
medicine. Increasing evidence reveals the strong links between 
genetics and human health, predicting those associations that will 
provide effective decision support for medical and clinical 
researchers. Compared to the earlier published version, we 
involved more categories of biomedical entities and centrality 
measurement approach to modify the research framework, 
through which we respectively added genetic variants into our 
predicting scope and identified critical genetic factors that 
function in the pathogenesis of the target disease.  
This paper proposed a hybrid method for predicting the 
associations between diseases and genes from the standpoint of 
bibliometrics, based on the co-occurrence and semantic 
similarities of genetic factors and diseases. The advantages of our 
method are that we made use of text data in the latest published 
papers and took semantic relationships into consideration. By 
designing a cross-validation experiment, we compared our hybrid 
method with other classical ones and found that our method shows 
better performance. Furthermore, the predicted relationships are 
identified in the latest studies, proving the credibility and validity 
of our proposed method. 
Apart from this case study on gene-related atrial fibrillation, the 
proposed method is expected to be applied to a broad range of 
investigations on discovering the relationships between genes and 
specific diseases. Such efforts could be expected to provide 
extensive and objective insights from global scientific articles to 
support decision making in related medical research and clinical 
practices, such as helping researchers identify unknown 
relationships between specific genes and diseases and propose 
effective treatments from globally published research, studies, and 
cases.  
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There are also several limitations of this paper that may require 
further investigation in future studies: 1) Although we exploited 
the developed Pubtator as our biomedical entity extraction tool, 
there exist inevitably some false positives in the entity extraction 
process beyond our control, how to avoid the impact of using 
those toolkits is one of our concerns in the future; 2) we 
emphasized on the completeness of collecting strong association 
by adopting co-occurrence analysis, but this process would 
include some negative associations like “A is not associated with 
B”, in the future studies, sentiment analysis would be a promising 
approach to reduce the false positives. 3) Limited expertise is 
employed here to validate and explain our predicting results. In 
the future study, we plan to establish a cardiovascular specialist 
panel to provide expert instructions and interpretations of our 
outcomes. 
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